ArticleBMJ open2024

Recombinant fragment of human surfactant protein D to prevent neonatal chronic lung disease (RESPONSE): a protocol for a phase I safety trial in a tertiary neonatal unit.

Reena Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.